Better diagnosis, better compliance and less waste are goals of patient evaluation surveys
A pilot program has shown the feasibility of conducting scientifically valid national surveys of patients regarding their doctors and providing the reports publicly.
Consumers' Checkbook/Center for the Study of Services (CSS), a nonprofit consumer research organization, surveyed patients in Kansas City, Denver, and Memphis.
Participating plans also agreed to license the survey results for a fee to use as they see fit. (Non-participating plans will not be granted use of the survey results.) According to the company, the survey model costs about $100 to $120 per doctor.
Aetna's Chief Medical Officer Lonny Reisman, MD, believes the approach improves the health plan's ability to gather sufficient patient feedback on each doctor to provide scientifically valid and meaningful information.
"The more people weighing in, the more credible and useful the information will be," Dr. Reisman says. "Sharing reliable patient input with doctors and consumers adds a valuable dimension to existing tools that engage health plan members by helping them evaluate quality as well as cost."
Physicians in the pilot metro areas have been cooperative in survey efforts, says Krughoff.
Study Highlights Critical Need For Improved Understanding of Childhood Interstitial Lung Disease
December 10th 2024Diagnostic criteria for pulmonary fibrosis and other fibrotic diseases in children are lacking. That void hampers an understanding of how disease progresses in children and adolescents and what the outcomes are.
Read More
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
More Than 400 Plastic Chemicals Could Be Linked to Breast Cancer
December 10th 2024Researchers have compiled a list of chemicals commonly found in plastics, including benzophenones, chlorinated paraffins and PFAS, known as “forever chemicals,” and they say there might be a connection to breast cancer.
Read More
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen